Delivery Order SPE2DB22D3016-SPE2DB25FAPP6
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,834.82 firm fixed-price delivery order contract has a completion date of November 29, 2023 and is not designated as a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $15,972.40. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $10,731.69. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $21,817.13. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type, and has an ultimate completion date of July 29, 2024. The contract is not designated as a...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml size. The contract, awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 28, 2025. The award has a ceiling value of $17,149.48 and is a firm fixed-price delivery order contract with a completion date of January 29, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,805.87 firm fixed price delivery order contract has a completion date of May 2, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The firm-fixed-price delivery order, valued at $22,518.80, has a period of performance ending on September 13, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,055.64, is a delivery order with a firm fixed price pricing type. It has an ultimate completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen with a ceiling value of $35,108.30. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $14,684.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Dupixent (300 mg/2 ml pen, 2 ml) to support U.S. government medical programs. The contract is a firm-fixed-price delivery order with a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...